Solutions for Clinical Research


Your Global Partner in Clinical Research Science
Delivering Quality, Clinically-relevant Science on Time and within Budget.

Synexa is a global leader in biomarker and bioanalytical science, with deep expertise in the immunological underpinning of health and disease.

We offer a comprehensive range of analytical and advisory services to clients comprising the identification, development,
validation, analysis and interpretation of biomarker and bioanalytical readouts in translational and clinical research. Our developing global network of labs serve our client base of primarily Biotech and Pharma companies, either directly or via a CRO.

We are dedicated to providing quality, clinically relevant solutions, and all activities across all our sites are performed in
compliance with GCLP which incorporate the relevant GCP/GLP guidelines, under the guidance and watchful eyes of our Quality Assurance team.


Biomarker Science Solutions
We use innovative approaches and validated platforms to answer client-specific questions related to biomarkers at each level of the biological continuum including questions related to biomarker discovery, validation, or data interpretation. We work in a collaborative manner with our clients to provide customized, flexible and multi-faceted biomarker solutions.
We pursue an integrated approach across the biological continuum which allows for deeper insight into the drug/target interactions at a molecular level, and obtaining robust data and biological response across specimens spanning biological specimens from nucleic acids to tissue.


Bioanalytical Science and Bespoke Assay Solutions
Synexa integrates a world-class scientific foundation with professional service delivery, combining solid scientific and regulatory knowledge with the latest technology platforms and expertise across a wide range of therapeutic areas.


Our human in vitro translational
ProtoTrials® platform bridges the gap
between animal models and humans
and is ideal for applications within PD,
Safety, Drug Benchmarking and
Biomarker Discovery.


We offer extensive experience in large molecule bioanalysis, supporting our biopharma partners through all phases of method development, validation and across various clinical applications.


We have decades of experience in developing and implementing optimal biomarker strategies, providing Insights that will improve the quality of decision-making through each stage of a therapeutic’s development.

Novel Modality Bioanalytics

Novel drug modalities or new drug entities require a careful and thorough analytical approach. Drawing from a wide range of experience in this field, we can guide and tailor each study according to the desired endpoints.

Custom Assay Solutions

Our scientists have proven expertise in the field of bespoke assay method development and validation, producing methods that are considerate of regulatory requirements and provide quality, reproducible and robust data.

Areas of Specialty

We have globally-recognised expertise in key therapeutic areas across every stage of clinical development with particular emphasis on immunology, immuno-oncology and autoimmune diseases.
Synexa specializes in providing bespoke end-to-end solutions, developed and validated to meet your specific challenges. Bespoke bioassay solutions are paired with proven advanced technology platforms, capable of assessing biomarkers across the biological spectrum, providing trusted results.

Therapeutic expertise and research phase expertise

Expertise in your targeted therapeutic area across all clinical phases.
We support clinical programs in a wide selection of key therapeutic areas including:
Synexa’s global setup aims to support partners from preclinical translational research and biomarker development through to clinical bioanalysis of established and novel drug modalities.

Our Global Laboratory Network

Quality science delivered on time and within budget
Our global laboratory network promises quality and consistency at each step of your project, no matter your location.

Advance your therapeutic pipeline.

Enquire now to see how our unparalleled scientific expertise can advance your therapeutic pipeline.